Last week’s judgment from the Court of Justice of the European Union (“CJEU”) in the landmark AstraZeneca v Commission case appeared to represent another resounding victory for the European Commission (“Commission”) and a defeat for the innovative pharmaceutical industry.
- How-to guide How-to guide: How to assess competition law risks in an agency agreement (UK)
- How-to guide How-to guide: Understanding antitrust and unfair trade practices law and your organization’s compliance obligations (USA)
- How-to guide How-to guide: How to draft an antitrust–unfair trade practices compliance program (USA)